Chomienne, FR
Christine Chomienne, Paris FR
Patent application number | Description | Published |
---|---|---|
20080213314 | COMBINED DNA VACCINE AND BIOLOGICAL MODIFIERS FOR CANCER THERAPY - The present invention relates to the combination of a DNA vaccination strategy that makes use of a nucleic acid encoding an immunogenic polypeptide, with a non-immunosuppressive inducer of tumor cell differentiation and/or apoptosis or a tumor cell modifier, useful for cancer therapy. Vaccine compositions and kits are provided, as well as specific nucleic acid constructs that are particularly suitable for the preparation of such compositions. | 09-04-2008 |
20120076828 | KANAMYCIN ANTISENSE NUCLEIC ACID FOR THE TREATMENT OF CANCER - The invention relates to a nucleic acid comprising a sequence complementary to a fragment of the sequence coding for the kanamycin resistance protein. This nucleic acid is useful as a DNA vaccine adjuvant, and can be used e.g. for treating cancer, for example in combination with a non-immunosuppressive inducer of tumor cell apoptosis such as all-trans retinoic acid (ATRA). | 03-29-2012 |
Odile Chomienne, Altkirch FR
Patent application number | Description | Published |
---|---|---|
20080300279 | PIPERIDINE-AMIDE DERIVATIVES - The invention is concerned with novel piperidine-amide derivatives of formula (I) | 12-04-2008 |
20090270500 | 4-TRIMETHYLAMMONIO-BUTYRATES AS CPT2 INHIBITORS - This invention relates to novel 4-trimethylammoniobutyrates of the formula | 10-29-2009 |
20090270505 | 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES - This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula | 10-29-2009 |
20100130484 | NOVEL BICYCLIC SULFONAMIDE DERIVATIVES WHICH ARE L-CPT1 INHIBITORS - The invention is concerned with novel heterobicyclic derivatives of formula (I) | 05-27-2010 |
20100144762 | NOVEL SULFONAMIDES AS L-CPT1 INHIBITORS - The invention is concerned with novel sulfonamide derivatives of formula (I) | 06-10-2010 |
20110015234 | INDAZOLE DERIVATIVES - The invention is concerned with novel indazole derivatives of formula (I) | 01-20-2011 |
20110046112 | NOVEL BICYCLIC SULFONAMIDE DERIVATIVES WHICH ARE L-CPT1 INHIBITORS - The invention is concerned with novel heterobicyclic derivatives of formula (I) | 02-24-2011 |
20110319438 | NOVEL SULFONAMIDES AS L-CPT1 INHIBITORS - The invention is concerned with novel sulfonamide derivatives of formula (I) | 12-29-2011 |
20120232104 | NOVEL SULFONAMIDES AS L-CPT1 INHIBITORS - The invention is concerned with novel sulfonamide derivatives of formula (I) | 09-13-2012 |
20120289554 | 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES - This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula | 11-15-2012 |
20130030033 | 4-TRIMETHYLAMMONIO-BUTYRATES AS CPT2 INHIBITORS - This invention relates to novel 4-trimethylammoniobutyrates of the formula | 01-31-2013 |